Literature DB >> 13172389

Some observations on an ascitic Rous No. 1 sarcoma.

R BATHER.   

Abstract

Entities:  

Keywords:  SARCOMA/experimental

Mesh:

Year:  1954        PMID: 13172389      PMCID: PMC2007926          DOI: 10.1038/bjc.1954.10

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  4 in total

1.  Nuclei from normal and leukemic mouse spleen. III. The desoxypentosenucleic acid content per nucleus calculated from total cell counts.

Authors:  N A MIZEN; M L PETERMANN
Journal:  Cancer Res       Date:  1952-10       Impact factor: 12.701

2.  Electron microscopy of chick embryo membrane infected with PR-8 influenza.

Authors:  R W G WYCKOFF
Journal:  Nature       Date:  1951-10-13       Impact factor: 49.962

3.  Relation between the amount of virus material and infectivity of Rous No. 1 sarcomata.

Authors:  R BATHER
Journal:  Br J Cancer       Date:  1953-12       Impact factor: 7.640

4.  The behaviour of ascites tumour cells in vitro and in vivo.

Authors:  I LASNITZKI
Journal:  Br J Cancer       Date:  1953-06       Impact factor: 7.640

  4 in total
  5 in total

1.  [Development and biological properties of MCal mouse ascites tumor].

Authors:  G MENGES; N SCHUMMELFEDER; W WESSEL
Journal:  Z Krebsforsch       Date:  1956

2.  [Some recent studies on the production and growth characteristics of ascites tumors; a review].

Authors:  G KLEIN
Journal:  Z Krebsforsch       Date:  1956

3.  A Triturate and Filtrate Transmissible Avian Fibromyxosarcoma Found in Nigeria, West Africa.

Authors:  O S Davis; D H Hill
Journal:  Can J Comp Med Vet Sci       Date:  1960-06

4.  Observations on the eclipse phase in a virus-associated erythroleukaemia of the chicken.

Authors:  J G CAMPBELL
Journal:  Br J Cancer       Date:  1954-12       Impact factor: 7.640

5.  Growth characteristics of the Rous No. 1 sarcoma grown in the peritoneal cavity of chickens.

Authors:  R BATHER
Journal:  Br J Cancer       Date:  1954-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.